Related Experiment Video
Updated: Sep 14, 2025

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells
Published on: February 4, 2021
Prevalence and risk factors for asymptomatic venous thromboembolism in patients with primary brain tumors
Viktoria Nemecz1, Reinhard B Raggam1, Tadeja Urbanic-Purkart2
1Division of Angiology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
Abstract:
Patients with primary brain tumors have a high risk of venous thromboembolism (VTE). This study aims to estimate the prevalence of asymptomatic VTE and to identify risk factors and biomarkers for asymptomatic VTE in patients with brain tumors by screening for asymptomatic LE-DVT. Fifty patients were included in the study. Nine patients (18%) experienced a VTE event during the study period. The cumulative 12-month incidence of prospective VTE was 14%. In an exploratory analysis of all VTE events, higher Galectin-3 levels were significantly associated with any VTE event (SOR = 2.35, 95% CI: 1.04-5.34; p = 0.04). According to time-to-VTE regression analyses, higher D-dimer, Galectin-3 levels, and von Willebrand factor activity were predictive of increased VTE risk. This study revealed a high prevalence of asymptomatic LE-DVT in patients with primary brain tumors and found that galectin-3 may be used as a biomarker to identify patients with primary brain tumors at high risk of VTE.
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Aneurysm II: Clinical Manifestations and Diagnostic Studies

